Due to the great potential of these three markers (HER-2, MMP-2, and MMP-9) in the prognosis and treatment of advanced stages of gastric cancer, and the absence of investigations directly comparing MMP-2 andMMP-9 with HER-2 expression, we decided to evaluate this subject. The gene discussed is MMP9; the disease is gastric cancer.